FALSE000163642200016364222023-06-142023-06-140001636422dei:FormerAddressMember2023-06-142023-06-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
FORM 8-K
__________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 13, 2024
__________________________________________________________
HEALTH CATALYST, INC.
(Exact name of registrant as specified in its charter)
________________________________________________________________
Delaware001-3899345-3337483
(State or other jurisdiction of
incorporation)
(Commission File Number)(IRS Employer
Identification No.)
10897 South River Front Parkway #300
South Jordan, UT 84095
(Address of principal executive offices, including zip code)

(801) 708-6800
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
______________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
______________________________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of exchange on which registered
Common Stock, par value $0.001 per shareHCATThe Nasdaq Global Select Market
________________________________________________________
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ((§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 13, 2024, Health Catalyst, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The Company’s stockholders voted on three proposals at the Annual Meeting, each of which is described in greater detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 29, 2024. The number of shares of the Company's common stock entitled to vote at the Annual Meeting was 59,033,536. The number of shares of the Company’s common stock present or represented by valid proxy at the Annual Meeting was 49,177,309. The final voting results with respect to each such proposal are set forth below.

Proposal 1 – Election of Directors
The Company’s stockholders elected each of the three persons named below to serve as a Class II director of the Company to serve a three-year term expiring at the 2027 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation. The results of such vote were as follows:

Director Name
Votes For
Votes Withheld
Broker Non-Votes
Daniel Burton31,119,44912,090,3335,967,527
John A. Kane30,312,85212,896,9305,967,527
Julie Larson-Green30,723,38412,486,3985,967,527


Proposal 2 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm
The Company’s stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2024. The results of such vote were as follows:

Votes ForVotes AgainstAbstentions
49,068,137106,6622,510


Proposal 3 – Advisory, Non-Binding Vote to Approve the Compensation of the Company’s Named Executive Officers
The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company’s named executive officers. The results of such vote were as follows:
Votes For
Votes Against
AbstentionsBroker Non-Votes
42,599,851597,26212,6695,967,527


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTH CATALYST, INC.
Date: June 17, 2024By:/s/ Jason Alger
Jason Alger
Chief Financial Officer


v3.24.1.1.u2
Cover Page
Jun. 14, 2023
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Jun. 13, 2024
Entity Registrant Name HEALTH CATALYST, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38993
Entity Tax Identification Number 45-3337483
Entity Address, Address Line One 10897 South River Front Parkway
Entity Address, Address Line Two #300
Entity Address, City or Town South Jordan
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84095
City Area Code 801
Local Phone Number 708-6800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol HCAT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001636422
Former Address  
Entity Information [Line Items]  
Entity Address, Address Line One Not Applicable
Health Catalyst (NASDAQ:HCAT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Health Catalyst Charts.
Health Catalyst (NASDAQ:HCAT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Health Catalyst Charts.